Get the Stockscreener App
24.73
0.24%
0.06
After Hours:
24.73
Fidelity Disruptive Medicine Etf Stock (FMED) Forecast
The Fidelity Disruptive Medicine Etf (FMED) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $26.86, representing a +8.61% increase from the current price of $24.73. The highest analyst price target is $27.92, and the lowest is $25.80.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FMED Price Target
Average 27.39
(+10.74% Upside)
Is Fidelity Disruptive Medicine Etf (FMED) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 31.43 | Neutral |
| STOCH(9,6) | 30.30 | Neutral |
| STOCHRSI(14) | 4.1294 | Buy |
| MACD(12,26) | -0.1722 | Sell |
| ADX(14) | 17.38 | Neutral |
| William %R | -96.94 | Buy |
| CCI(14) | -187.16 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
25.83
Sell
|
25.57
Sell
|
| MA20 |
25.83
Sell
|
25.76
Sell
|
| MA50 |
25.98
Sell
|
25.79
Sell
|
| MA100 |
25.47
Sell
|
25.48
Sell
|
| MA200 |
24.98
Sell
|
24.81
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, FMED could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on FMED, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 31.43 indicates that FMED is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 30.3 indicates that FMED is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.1294 indicates that FMED is oversold. This suggests that FMED price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.38 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -187.16 indicates that FMED is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term FMED price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Fidelity Disruptive Medicine Etf financial reports and earnings history, Fidelity Disruptive Medicine Etf (FMED) stock could reach $42.79 by 2030, $80.16 by 2040 and $108.29 by 2050. See the projected annual prices until 2050 of the Fidelity Disruptive Medicine Etf stock below:
- Fidelity Disruptive Medicine Etf (FMED) is expected to reach an average price of $61.92 in 2035, with a high prediction of $61.94 and a low estimate of $60.69. This indicates an $150.39% rise from the last recorded price of $24.73.
- Fidelity Disruptive Medicine Etf (FMED) stock is projected to chart a bullish course in 2040, with an average price target of $79.89, representing an $223.07% surge from its current level. The forecast ranges from a conservative $79.33 to a sky-high $80.16.
- Our analysts predict Fidelity Disruptive Medicine Etf (FMED) to jump 264.14% by 2045, soaring from $89.97 to an average price of $90.05, potentially reaching $97.27. While $89.97 is the low estimate, the potential upside is significant.
- Fidelity Disruptive Medicine Etf (FMED) stock is expected to climb by 2050, reaching an average of $108.29, a $337.89% jump from its current level. However, a wide range of estimates exists, with high and low targets of $108.29 and $106.08, respectively, highlighting the market's uncertainty.
Fidelity Disruptive Medicine Etf Stock (FMED) Year by Year Forecast
Fidelity Disruptive Medicine Etf Stock (FMED) Price Forecast for 2024
Our forecast for FMED stock price in 2024 now indicates an average price target of $25.08 with a high forecast of $28.04 and a low forecast of $22.12. The average prediction reflects an increase of +1.41% from the last recorded price of $24.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $26.37 | $25.80 | $27.92 | +6.61% |
Fidelity Disruptive Medicine Etf Stock (FMED) Price Forecast for 2025
Fidelity Disruptive Medicine Etf Stock (FMED) is expected to reach an average price of $27.87 in 2025, with a high prediction of $31.38 and a low estimate of $24.36. This indicates an +12.69% rise from the last recorded price of $24.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $25.45 | $25.45 | $26.79 | +2.91% |
| February, 2025 | $24.74 | $24.36 | $25.65 | +0.04% |
| March, 2025 | $26.39 | $24.85 | $26.39 | +6.71% |
| April, 2025 | $28.36 | $26.28 | $29.08 | +14.69% |
| May, 2025 | $28.79 | $28.23 | $29.18 | +16.43% |
| June, 2025 | $29.85 | $28.76 | $30.09 | +20.71% |
| July, 2025 | $29.77 | $29.34 | $30.40 | +20.39% |
| August, 2025 | $28.33 | $28.21 | $30.42 | +14.55% |
| September, 2025 | $28.55 | $28.03 | $29.22 | +15.44% |
| October, 2025 | $27.82 | $26.59 | $28.88 | +12.50% |
| November, 2025 | $28.32 | $26.71 | $28.51 | +14.50% |
| December, 2025 | $31.12 | $28.22 | $31.38 | +25.83% |
Fidelity Disruptive Medicine Etf Stock (FMED) Price Forecast for 2026
The predicted value for Fidelity Disruptive Medicine Etf (FMED) in 2026 is set at an average of $32.02. Estimates vary from a peak of $35.20 to a trough of $28.83, indicating an +29.46% surge from the present price of $24.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $31.10 | $30.51 | $31.44 | +25.77% |
| February, 2026 | $32.15 | $31.05 | $32.44 | +30.00% |
| March, 2026 | $32.44 | $31.85 | $32.77 | +31.16% |
| April, 2026 | $31.60 | $31.52 | $32.81 | +27.76% |
| May, 2026 | $31.24 | $30.62 | $31.85 | +26.32% |
| June, 2026 | $28.93 | $28.89 | $31.10 | +16.97% |
| July, 2026 | $30.72 | $28.83 | $30.77 | +24.22% |
| August, 2026 | $32.48 | $30.35 | $32.75 | +31.32% |
| September, 2026 | $33.11 | $31.99 | $33.75 | +33.88% |
| October, 2026 | $34.38 | $33.11 | $34.45 | +39.03% |
| November, 2026 | $34.81 | $33.90 | $35.13 | +40.77% |
| December, 2026 | $34.36 | $34.01 | $35.20 | +38.93% |
Fidelity Disruptive Medicine Etf Stock (FMED) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Fidelity Disruptive Medicine Etf (FMED) is $34.33, with a high forecast of $37.59 and a low forecast of $31.07. This indicates an +38.83% increase from the last price of $24.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $33.58 | $33.04 | $34.83 | +35.80% |
| February, 2027 | $32.13 | $32.13 | $34.08 | +29.91% |
| March, 2027 | $32.51 | $31.07 | $32.73 | +31.45% |
| April, 2027 | $33.46 | $32.53 | $33.67 | +35.28% |
| May, 2027 | $35.28 | $33.32 | $35.98 | +42.66% |
| June, 2027 | $36.21 | $35.18 | $36.24 | +46.44% |
| July, 2027 | $36.96 | $36.06 | $37.49 | +49.45% |
| August, 2027 | $36.93 | $36.48 | $37.39 | +49.34% |
| September, 2027 | $36.04 | $35.45 | $37.59 | +45.72% |
| October, 2027 | $34.57 | $34.49 | $36.51 | +39.81% |
| November, 2027 | $34.55 | $33.31 | $35.14 | +39.72% |
| December, 2027 | $35.49 | $33.46 | $35.49 | +43.51% |
Fidelity Disruptive Medicine Etf Stock (FMED) Price Forecast for 2028
In 2028, Fidelity Disruptive Medicine Etf (FMED) is projected to reach an average price of $38.81, with a high projection of $42.21 and a low estimate of $35.41. This indicates an +56.94% rise from the last price of $24.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $38.02 | $35.41 | $38.28 | +53.73% |
| February, 2028 | $38.08 | $37.43 | $38.37 | +53.97% |
| March, 2028 | $39.27 | $38.05 | $39.49 | +58.81% |
| April, 2028 | $39.01 | $38.86 | $39.85 | +57.76% |
| May, 2028 | $37.97 | $37.86 | $39.99 | +53.56% |
| June, 2028 | $37.40 | $36.88 | $38.94 | +51.23% |
| July, 2028 | $35.93 | $35.54 | $37.75 | +45.31% |
| August, 2028 | $37.39 | $35.71 | $37.56 | +51.20% |
| September, 2028 | $39.60 | $37.32 | $39.67 | +60.11% |
| October, 2028 | $40.06 | $39.73 | $40.69 | +62.01% |
| November, 2028 | $41.55 | $40.08 | $41.84 | +68.00% |
| December, 2028 | $41.93 | $41.27 | $42.21 | +69.56% |
Fidelity Disruptive Medicine Etf Stock (FMED) Price Forecast for 2029
The 2029 price forecast for Fidelity Disruptive Medicine Etf Stock (FMED) is $41.28 on average, with a high prediction of $44.77 and a low estimate of $37.78. This represents an +66.91% increase from the previous price of $24.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $41.22 | $41.14 | $42.38 | +66.67% |
| February, 2029 | $40.89 | $40.27 | $41.50 | +65.33% |
| March, 2029 | $37.85 | $37.81 | $39.97 | +53.06% |
| April, 2029 | $39.28 | $37.78 | $39.50 | +58.82% |
| May, 2029 | $41.62 | $39.32 | $41.90 | +68.32% |
| June, 2029 | $42.57 | $41.17 | $43.00 | +72.13% |
| July, 2029 | $43.23 | $42.14 | $43.25 | +74.79% |
| August, 2029 | $44.28 | $43.09 | $44.58 | +79.07% |
| September, 2029 | $44.66 | $43.62 | $44.77 | +80.60% |
| October, 2029 | $43.28 | $42.68 | $44.71 | +75.01% |
| November, 2029 | $41.03 | $41.03 | $43.80 | +65.90% |
| December, 2029 | $40.49 | $40.02 | $41.40 | +63.73% |
Fidelity Disruptive Medicine Etf Stock (FMED) Price Forecast for 2030
Fidelity Disruptive Medicine Etf Stock (FMED) is expected to reach an average price of $44.77 in 2030, with a high forecast of $48.88 and a low forecast of $40.65. This signifies an +81.02% surge from the last price of $24.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $42.58 | $40.65 | $42.79 | +72.18% |
| February, 2030 | $44.50 | $42.47 | $45.18 | +79.96% |
| March, 2030 | $45.11 | $44.46 | $45.50 | +82.41% |
| April, 2030 | $46.34 | $45.12 | $46.54 | +87.39% |
| May, 2030 | $46.48 | $46.00 | $46.94 | +87.95% |
| June, 2030 | $45.21 | $45.09 | $47.17 | +82.81% |
| July, 2030 | $43.45 | $43.37 | $46.23 | +75.70% |
| August, 2030 | $43.53 | $42.26 | $44.04 | +76.02% |
| September, 2030 | $44.20 | $42.46 | $44.35 | +78.72% |
| October, 2030 | $47.22 | $44.15 | $47.48 | +90.93% |
| November, 2030 | $47.38 | $46.65 | $47.62 | +91.57% |
| December, 2030 | $48.59 | $47.37 | $48.88 | +96.50% |
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):